166 related articles for article (PubMed ID: 32087569)
1. Specificity of human natural antibodies referred to as anti-Tn.
Dobrochaeva K; Khasbiullina N; Shilova N; Antipova N; Obukhova P; Ovchinnikova T; Galanina O; Blixt O; Kunz H; Filatov A; Knirel Y; LePendu J; Khaidukov S; Bovin N
Mol Immunol; 2020 Apr; 120():74-82. PubMed ID: 32087569
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
Mazal D; Lo-Man R; Bay S; Pritsch O; Dériaud E; Ganneau C; Medeiros A; Ubillos L; Obal G; Berois N; Bollati-Fogolin M; Leclerc C; Osinaga E
Cancer Immunol Immunother; 2013 Jun; 62(6):1107-22. PubMed ID: 23604173
[TBL] [Abstract][Full Text] [Related]
3. Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM).
Arend P
Cancer Med; 2017 Jul; 6(7):1601-1613. PubMed ID: 28580709
[TBL] [Abstract][Full Text] [Related]
4. Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.
Koizumi T; Matsumoto-Takasaki A; Nakada H; Nakata M; Fujita-Yamaguchi Y
Biosci Trends; 2010 Dec; 4(6):308-11. PubMed ID: 21248428
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.
Blixt O; Lavrova OI; Mazurov DV; Cló E; Kracun SK; Bovin NV; Filatov AV
Glycobiology; 2012 Apr; 22(4):529-42. PubMed ID: 22143985
[TBL] [Abstract][Full Text] [Related]
6. Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.
Oppezzo P; Osinaga E; Tello D; Bay S; Cantacuzene D; Irigoín F; Ferreira A; Roseto A; Cayota A; Alzari P; Pritsch O
Hybridoma; 2000 Jun; 19(3):229-39. PubMed ID: 10952411
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy.
Osinaga E; Bay S; Tello D; Babino A; Pritsch O; Assemat K; Cantacuzene D; Nakada H; Alzari P
FEBS Lett; 2000 Mar; 469(1):24-8. PubMed ID: 10708749
[TBL] [Abstract][Full Text] [Related]
8. Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides.
Sharma P; Marada VVVR; Cai Q; Kizerwetter M; He Y; Wolf SP; Schreiber K; Clausen H; Schreiber H; Kranz DM
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15148-15159. PubMed ID: 32541028
[TBL] [Abstract][Full Text] [Related]
9. A Synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells.
Leiria Campo V; Riul TB; Oliveira Bortot L; Martins-Teixeira MB; Fiori Marchiori M; Iaccarino E; Ruvo M; Dias-Baruffi M; Carvalho I
Chembiochem; 2017 Mar; 18(6):527-538. PubMed ID: 28068458
[TBL] [Abstract][Full Text] [Related]
10. Purified human anti-Tn and anti-T antibodies specifically recognize carcinoma tissues.
Zlocowski N; Grupe V; Garay YC; Nores GA; Lardone RD; Irazoqui FJ
Sci Rep; 2019 May; 9(1):8097. PubMed ID: 31147593
[TBL] [Abstract][Full Text] [Related]
11. Detection of tumor-associated glycopeptides by lectins: the peptide context modulates carbohydrate recognition.
Madariaga D; Martínez-Sáez N; Somovilla VJ; Coelho H; Valero-González J; Castro-López J; Asensio JL; Jiménez-Barbero J; Busto JH; Avenoza A; Marcelo F; Hurtado-Guerrero R; Corzana F; Peregrina JM
ACS Chem Biol; 2015 Mar; 10(3):747-56. PubMed ID: 25457745
[TBL] [Abstract][Full Text] [Related]
12. Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.
Marcelo F; Supekar N; Corzana F; van der Horst JC; Vuist IM; Live D; Boons GPH; Smith DF; van Vliet SJ
J Biol Chem; 2019 Jan; 294(4):1300-1311. PubMed ID: 30504228
[TBL] [Abstract][Full Text] [Related]
13. Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides.
Blixt O; Allin K; Pereira L; Datta A; Paulson JC
J Am Chem Soc; 2002 May; 124(20):5739-46. PubMed ID: 12010048
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
Lo-Man R; Vichier-Guerre S; Bay S; Dériaud E; Cantacuzène D; Leclerc C
J Immunol; 2001 Feb; 166(4):2849-54. PubMed ID: 11160353
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).
Steentoft C; Schjoldager KT; Cló E; Mandel U; Levery SB; Pedersen JW; Jensen K; Blixt O; Clausen H
Glycoconj J; 2010 Aug; 27(6):571-82. PubMed ID: 20721622
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
[TBL] [Abstract][Full Text] [Related]
17. Antibody recognition of a unique tumor-specific glycopeptide antigen.
Brooks CL; Schietinger A; Borisova SN; Kufer P; Okon M; Hirama T; Mackenzie CR; Wang LX; Schreiber H; Evans SV
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10056-61. PubMed ID: 20479270
[TBL] [Abstract][Full Text] [Related]
18. Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen.
Vichier-Guerre S; Lo-Man R; Bay S; Deriaud E; Nakada H; Leclerc C; Cantacuzène D
J Pept Res; 2000 Feb; 55(2):173-80. PubMed ID: 10784033
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
Sakai K; Yuasa N; Tsukamoto K; Takasaki-Matsumoto A; Yajima Y; Sato R; Kawakami H; Mizuno M; Takayanagi A; Shimizu N; Nakata M; Fujita-Yamaguchi Y
J Biochem; 2010 Jun; 147(6):809-17. PubMed ID: 20147453
[TBL] [Abstract][Full Text] [Related]
20. Polyvalency of Tn (GalNAcalpha1-->Ser/Thr) glycotope as a critical factor for Vicia villosa B4 and glycoprotein interactions.
Wu AM
FEBS Lett; 2004 Mar; 562(1-3):51-8. PubMed ID: 15044001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
